Promoter variants for expressing genes in a fungal cell

    公开(公告)号:US09695429B2

    公开(公告)日:2017-07-04

    申请号:US14850448

    申请日:2015-09-10

    Abstract: The present invention relates to methods for producing a biological substance, comprising: (a) cultivating a fungal host cell in a medium conducive for the production of the biological substance, wherein the fungal host cell comprises a first nucleic acid sequence encoding the biological substance operably linked to a second nucleic acid sequence comprising a promoter variant selected from the group consisting of SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 5, SEQ ID NO: 6, SEQ ID NO: 7, SEQ ID NO: 8, SEQ ID NO: 9, SEQ ID NO: 10, SEQ ID NO: 11, and SEQ ID NO: 12; and a subsequence thereof; and hybrid and tandem promoters thereof; and (b) isolating the biological substance from the cultivation medium. The present invention also relates to the isolated promoter variants and to constructs, vectors, and fungal host cells comprising the promoter variants operably linked to nucleic acid sequences encoding biological substances.

    Lipase variants for pharmaceutical use
    23.
    发明授权
    Lipase variants for pharmaceutical use 有权
    用于药物用途的脂肪酶变体

    公开(公告)号:US09539311B2

    公开(公告)日:2017-01-10

    申请号:US14679563

    申请日:2015-04-06

    CPC classification number: A61K38/465 A61K38/47 A61K38/48 C12N9/20

    Abstract: The pharmaceutical use of lipases related to the Thermomyces lanuginosus (Humicola lanuginosa) lipase comprising amino acids 1-269 of SEQ ID NO: 2, optionally in combination with a protease and/or an amylase. Examples of medical indications are: Treatment of digestive disorders, pancreatic exocrine insufficiency (PEI), pancreatitis, cystic fibrosis, diabetes type I, and/or diabetes type II. The lipases of the invention have, e.g., an improved digestion performance in vitro, an improved activity at a pH in the neutral range, an improved stability at low pH, an are stable against protease-degradation, and/or are stable in the presence of pepsin and bile salts. The invention also relates to methods of determining digestion performance in vitro of lipases, as well as to certain novel variants of the lipase of T. lanuginosus.

    Abstract translation: 与包含SEQ ID NO:2的氨基酸1-269的Thermomyces lanuginosus(Humicola lanuginosa)脂肪酶相关的脂肪酶的药物用途,任选地与蛋白酶和/或淀粉酶组合。 医学适应症的例子有:消化系统疾病,胰腺外分泌功能不全(PEI),胰腺炎,囊性纤维化,I型糖尿病和/或II型糖尿病的治疗。 本发明的脂肪酶具有例如体外改进的消化性能,在中性范围内的pH值改善的活性,在低pH下的改进的稳定性,对蛋白酶降解是稳定的,和/或在存在时是稳定的 的胃蛋白酶和胆汁盐。 本发明还涉及确定脂肪酶的体外消化性能的方法以及T.lanuginosus的脂肪酶的某些新颖变体。

    Promoter Variants For Expressing Genes In A Fungal Cell
    29.
    发明申请
    Promoter Variants For Expressing Genes In A Fungal Cell 审中-公开
    在真菌细胞中表达基因的启动子变体

    公开(公告)号:US20150376630A1

    公开(公告)日:2015-12-31

    申请号:US14850448

    申请日:2015-09-10

    Abstract: The present invention relates to methods for producing a biological substance, comprising: (a) cultivating a fungal host cell in a medium conducive for the production of the biological substance, wherein the fungal host cell comprises a first nucleic acid sequence encoding the biological substance operably linked to a second nucleic acid sequence comprising a promoter variant selected from the group consisting of SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 5, SEQ ID NO: 6, SEQ ID NO: 7, SEQ ID NO: 8, SEQ ID NO: 9, SEQ ID NO: 10, SEQ ID NO: 11, and SEQ ID NO: 12; and a subsequence thereof; and hybrid and tandem promoters thereof; and (b) isolating the biological substance from the cultivation medium. The present invention also relates to the isolated promoter variants and to constructs, vectors, and fungal host cells comprising the promoter variants operably linked to nucleic acid sequences encoding biological substances.

    Abstract translation: 本发明涉及生物体的制造方法,其特征在于,包括:(a)在有助于生物生物的培养基中培养真菌宿主细胞,其中所述真菌宿主细胞可操作地包含编码生物物质的第一核酸序列 连接到第二核酸序列,其包含选自SEQ ID NO:2,SEQ ID NO:3,SEQ ID NO:4,SEQ ID NO:5,SEQ ID NO:6,SEQ ID NO: :7,SEQ ID NO:8,SEQ ID NO:9,SEQ ID NO:10,SEQ ID NO:11和SEQ ID NO:12; 及其后果; 及其杂交和串联启动子; 和(b)从培养基中分离生物物质。 本发明还涉及分离的启动子变体和构建体,载体和真菌宿主细胞,其包含可操作地连接于编码生物物质的核酸序列的启动子变体。

    Promoter variants for expressing genes in a fungal cell
    30.
    发明授权
    Promoter variants for expressing genes in a fungal cell 有权
    用于在真菌细胞中表达基因的启动子变体

    公开(公告)号:US09150856B2

    公开(公告)日:2015-10-06

    申请号:US14097659

    申请日:2013-12-05

    Abstract: The present invention relates to methods for producing a biological substance, comprising: (a) cultivating a fungal host cell in a medium conducive for the production of the biological substance, wherein the fungal host cell comprises a first nucleic acid sequence encoding the biological substance operably linked to a second nucleic acid sequence comprising a promoter variant selected from the group consisting of SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 5, SEQ ID NO: 6, SEQ ID NO: 7, SEQ ID NO: 8, SEQ ID NO: 9, SEQ ID NO: 10, SEQ ID NO: 11, and SEQ ID NO: 12; and a subsequence thereof; and hybrid and tandem promoters thereof; and (b) isolating the biological substance from the cultivation medium. The present invention also relates to the isolated promoter variants and to constructs, vectors, and fungal host cells comprising the promoter variants operably linked to nucleic acid sequences encoding biological substances.

    Abstract translation: 本发明涉及生物体的制造方法,其特征在于,包括:(a)在有助于生物生物的培养基中培养真菌宿主细胞,其中所述真菌宿主细胞可操作地包含编码生物物质的第一核酸序列 连接到第二核酸序列,其包含选自SEQ ID NO:2,SEQ ID NO:3,SEQ ID NO:4,SEQ ID NO:5,SEQ ID NO:6,SEQ ID NO: :7,SEQ ID NO:8,SEQ ID NO:9,SEQ ID NO:10,SEQ ID NO:11和SEQ ID NO:12; 及其后果; 及其杂交和串联启动子; 和(b)从培养基中分离生物物质。 本发明还涉及分离的启动子变体和构建体,载体和真菌宿主细胞,其包含可操作地连接于编码生物物质的核酸序列的启动子变体。

Patent Agency Ranking